CODIAK Trademark

Trademark Overview

On Friday, February 8, 2019, a trademark application was filed for CODIAK with the United States Patent and Trademark Office. The USPTO has given the CODIAK trademark a serial number of 88294812. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, December 16, 2021. This trademark is owned by Codiak Biosciences, Inc.. The CODIAK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications, namely, biological preparations for the treatment of metabolic and fibrotic disorders, immune diseases, cancer, and neurological disorders; all of the foregoing excluding pharmaceutical drugs and medicines to treat ophthalmic diseases and diagnostic reagents for medical use

Biopharmaceutical research and development services related to extracellular vesicles known as exosomes, the foregoing excluding research and development related to ophthalmology or diagnostic reagents
codiak

General Information

Serial Number88294812
Word MarkCODIAK
Filing DateFriday, February 8, 2019
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, December 16, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of of the word "CODIAK", with 18 dots of various sizes emanating from the top of the letter "I".
Goods and ServicesBiological preparations comprising extracellular vesicles known as exosomes for therapeutic applications, namely, biological preparations for the treatment of metabolic and fibrotic disorders, immune diseases, cancer, and neurological disorders; all of the foregoing excluding pharmaceutical drugs and medicines to treat ophthalmic diseases and diagnostic reagents for medical use
Goods and ServicesBiopharmaceutical research and development services related to extracellular vesicles known as exosomes, the foregoing excluding research and development related to ophthalmology or diagnostic reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 4, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCodiak Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Thursday, January 27, 2022ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, December 16, 2021ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, December 16, 2021EXPARTE APPEAL TERMINATED
Friday, October 29, 2021EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Monday, August 16, 2021NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 16, 2021ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 16, 2021ACTION CONTINUING FINAL - COMPLETED
Tuesday, July 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 8, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, July 8, 2021EX PARTE APPEAL-INSTITUTED
Thursday, July 8, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, July 8, 2021EXPARTE APPEAL RECEIVED AT TTAB
Friday, January 8, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, January 8, 2021FINAL REFUSAL E-MAILED
Friday, January 8, 2021FINAL REFUSAL WRITTEN
Tuesday, December 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NON-FINAL ACTION WRITTEN
Saturday, May 30, 2020SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, November 20, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 20, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, November 20, 2019SUSPENSION LETTER WRITTEN
Wednesday, October 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2019ASSIGNED TO LIE
Tuesday, October 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019ATTORNEY REVIEW COMPLETED
Tuesday, May 7, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, May 7, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 22, 2019NON-FINAL ACTION E-MAILED
Monday, April 22, 2019NON-FINAL ACTION WRITTEN
Monday, April 22, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 12, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

codiak diseases reagents disorders biological diagnostic excluding foregoing development research vesicles